Final results of a phase I study of oral belinostat (PXD101) in patients with solid tumors

Authors

Publication/Presentation Date

5-2009

Volume

27

Issue

15

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

Department(s)

Administration and Leadership

Document Type

Article

Share

COinS